Source: PR Newswire

Press Release: Altavant Sciences : Altavant Sciences Initiates Phase 2a Study of Rodatristat Ethyl in Pulmonary Arterial Hypertension

CARY, N.C. and BASEL, Switzerland, Aug. 5, 2019 /PRNewswire/ -- Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug development in rare respiratory diseases, announced that it has dosed the first patient in the ELEVATE 1 proof-of-concept Phase 2a...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Bill Symonds's photo - CEO of Altavant Sciences


Bill Symonds

CEO Approval Rating


Altavant Sciences is a biopharmaceutical company that develops and commercializes drug-based therapy for the treatment of respiratory diseases. Read more